{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:32:52Z","timestamp":1780461172861,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.atherosclerosis.2019.05.017","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T02:54:05Z","timestamp":1558666445000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-1180","authenticated-orcid":false,"given":"Barbara","family":"Iyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-8237","authenticated-orcid":false,"given":"Ralph K.","family":"Akyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Leonardi-Bee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8221-6547","authenticated-orcid":false,"given":"Steve E.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5281-9590","authenticated-orcid":false,"given":"Stephen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib2","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","year":"1991","journal-title":"BMJ Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib5","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(98)00200-7","article-title":"Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"142","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2016.04.054","article-title":"Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality","volume":"68","author":"Besseling","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib8","series-title":"Familial Hypercholesterolaemia: Identification and Management National Institute for Health and Care Excellence","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.STR.0000047123.14312.3E","article-title":"Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study","volume":"34","author":"Huxley","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.118.033470","article-title":"Relationship of familial hypercholesterolemia and high low-density lipoprotein cholesterol to ischemic stroke","volume":"138","author":"Beheshti","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib11","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1210\/jc.2018-01058","article-title":"Familial hypercholesterolemia and risk of peripheral arterial disease and chronic kidney disease","volume":"103","author":"Emanuelsson","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.STR.19.9.1097","article-title":"Risk of brain infarction in familial hypercholesterolemia","volume":"19","author":"Kaste","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in us adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/oxfordjournals.aje.a009786","article-title":"Factors influencing the optimal control-to-case ratio in matched case-control studies","volume":"149","author":"Hennessy","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2188\/jea.JE20130062","article-title":"Is a cutoff of 10% appropriate for the change-in-estimate criterion of confounder identification?","volume":"24","author":"Lee","year":"2014","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/CLEP.S129785","article-title":"Missing data and multiple imputation in clinical epidemiological research","volume":"9","author":"Pedersen","year":"2017","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","article-title":"Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic","volume":"229","author":"Futema","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib20","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib21","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish familial hypercholesterolemia cohort study)","volume":"135","author":"Perez de Isla","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/heartjnl-2017-312706","article-title":"Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia","volume":"104","author":"Mundal","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib24","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.3399\/bjgp16X688837","article-title":"NHS Health Check comorbidity and management: an observational matched study in primary care","volume":"67","author":"Robson","year":"2017","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacl.2017.05.012","article-title":"Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients","volume":"11","author":"Zamora","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib26","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/01.STR.17.6.1142","article-title":"Familial hyperlipidemia in stroke in the young","volume":"17","author":"Bansal","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.STR.18.4.716","article-title":"Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid","volume":"18","author":"Kuo","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacl.2018.10.012","article-title":"Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: a systematic review and meta-analysis","volume":"13","author":"Akioyamen","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2015.01.028","article-title":"Would raising the total cholesterol diagnostic cut-off from 7.5 mmol\/L to 9.3 mmol\/L improve detection rate of patients with monogenic familial hypercholesterolaemia?","volume":"239","author":"Futema","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081998","article-title":"Availability and quality of coronary heart disease family history in primary care medical records: implications for cardiovascular risk assessment","volume":"9","author":"Dhiman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3399\/bjgp09X472674","article-title":"Identification and management of familial hypercholesterolaemia: what does it mean to primary care?","volume":"59","author":"Qureshi","year":"2009","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib33","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1038\/s41598-017-06101-6","article-title":"Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia","volume":"7","author":"Climent","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL-C genetic risk score in the diagnosis of the polygenic form of clinical Familial Hypercholesterolemia and replication in samples from six countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib35","article-title":"Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease","author":"Akyea","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2019.05.017_bib36","series-title":"Familial Hypercholesterolaemia \u2013 Implementing a Systems Approach to Detection and Management","author":"Public Health England","year":"2018"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019304423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019304423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:38:05Z","timestamp":1758155885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019304423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"alternative-id":["S0021915019304423"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.05.017","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}